We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

156 hedge funds and large institutions have $202M invested in Amneal Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.51% more ownership

Funds ownership: 65.78% → 67.29% (+1.5%)

1% more funds holding

Funds holding: 154 → 156 (+2)

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

1% more capital invested

Capital invested by funds: $200M → $202M (+$2.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less call options, than puts

Call options by funds: $119K | Put options by funds: $149K

Holders
156
Holders Change
+2
Holders Change %
+1.3%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
48
Reduced
47
Closed
27
Calls
$119K
Puts
$149K
Net Calls
-$30K
Net Calls Change
+$656K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$8.55M
2
Millennium Management
Millennium Management
New York
+$6.8M
3
Norges Bank
Norges Bank
Norway
+$6.08M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$2.61M
5
Bank of America
Bank of America
North Carolina
+$1.96M

Top Sellers

1
TGA
TPG GP A
Texas
-$8.71M
2
EP
Eversept Partners
New York
-$8.65M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.55M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.14M
5
JAM
Jupiter Asset Management
United Kingdom
-$1.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
51
Stifel Financial
Missouri
$279K +$551 +246 +0.2%
NYLIM
52
New York Life Investment Management
New York
$271K +$34.4K +15,329 +13%
AIMCA
53
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$261K +$294K +131,267 New
VRS
54
Virginia Retirement Systems
Virginia
$259K – – –
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$252K -$31 -14 -0%
Fidelity Investments
56
Fidelity Investments
Massachusetts
$246K +$1.48K +658 +0.5%
State of Tennessee, Department of Treasury
57
State of Tennessee, Department of Treasury
Tennessee
$207K +$234K +104,193 New
CAM
58
ClariVest Asset Management
California
$195K -$359 -160 -0.2%
State of Wisconsin Investment Board
59
State of Wisconsin Investment Board
Wisconsin
$184K -$12.7K -5,664 -6%
SWMP
60
Signature Wealth Management Partners
New Jersey
$174K – – –
Ameriprise
61
Ameriprise
Minnesota
$172K +$60.2K +26,851 +45%
UBS AM
62
UBS AM
Illinois
$169K – – –
BNP Paribas Financial Markets
63
BNP Paribas Financial Markets
France
$160K -$14.8K -6,598 -8%
Renaissance Technologies
64
Renaissance Technologies
New York
$152K -$147K -65,500 -46%
SOW
65
State of Wyoming
Wyoming
$152K +$54.5K +24,333 +47%
Assenagon Asset Management
66
Assenagon Asset Management
Luxembourg
$144K +$163K +72,578 New
TFA
67
Tranquilli Financial Advisor
New Jersey
$142K – – –
Principal Financial Group
68
Principal Financial Group
Iowa
$140K +$36.6K +16,339 +30%
SFI
69
Susquehanna Fundamental Investments
Pennsylvania
$134K -$238K -106,084 -61%
HF
70
HRT Financial
New York
$130K +$146K +65,354 New
CSS
71
Cubist Systematic Strategies
Connecticut
$129K -$156K -69,490 -52%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$129K -$119 -53 -0.1%
Barclays
73
Barclays
United Kingdom
$124K +$52.2K +23,286 +59%
CS
74
Credit Suisse
Switzerland
$123K -$549 -245 -0.4%
OQS
75
Occudo Quantitative Strategies
Florida
$122K +$57.2K +25,513 +71%
1 2
3
4 5

AMRX Hedge Fund Activity: Q4 2022 in Review

156 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2022, worth a combined $202M — up 1.2% from $200M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AMRX positions and 27 closed out — a net gain of 2 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $8.55M. The largest seller was TPG GP A, cutting an estimated $8.71M.

  • 156 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2022, up from 154 in Q3 2022.
  • Funds reported $202M of Amneal Pharmaceuticals stock for Q4 2022, up 1.2% quarter-over-quarter.
  • 29 funds opened new Amneal Pharmaceuticals positions in Q4 2022 and 27 closed out, a net change of +2 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2022 was Morgan Stanley, an estimated $8.55M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2022 was TPG GP A, an estimated $8.71M sold.

Based on aggregated 13F filings for Q4 2022.